Have You experienced Mabthera side effects? Select to Vote Yes, Severe Yes, Moderate Yes, Minor No View and Discuss Results

1.5 million people annually are harmed from drug errors. Don't Risk Your Health! Ask a Health Expert Now

From simple mix-ups to fatal overdoses, medication mistakes happen, on average, once a day to every hospital patient, a new report says. Nationwide, at least 1.5 million people annually are harmed from drug errors, more than half of them in nursing homes.
Many Unfavorable Drug Studies Aren’t Published. Nearly a third of antidepressant drug studies are never published in the medical literature, and nearly all of those happen to show that the drug being tests failed to work.
Only Drugs That are Safe Should be put on the Market. Drug developers are just beginning to come to grips with recent FDA oversight reforms and how they will affect drug safety. But, it appears that industry and consumer advocates are not together on how well the overhaul will be able to prevent future drug safety scandals.

      Advertisements

Health Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question about Mabthera? Ask a Health Expert!

Vaccine Safety

Menu

• Mabthera: Ask Health Expert
• Mabthera: Ask Legal Expert
• More About Mabthera
• Describe Your Side Effect
• FDA Warnings
• Avoid Medication Mistakes
• Mabthera Safety Poll
• Mabthera: Share Your Health Story
• Mabthera: Take Side Effects Survey and View Results
• Take Symptoms Survey and View Results
• Patient Wiki: Stories, Blogs, Surveys
• Hospital Quality Reports
• Home Care Quality

Community-reported Mabthera side effects:

Add Your Side Effect to the Community Database

Help Community - Describe Your Mabthera Side Effect Episode

Have You dealt with a Mabthera side effect? Share your experience

A Health Expert wants to answer your Mabthera question. Please provide details below. Type your question here

 letters left

Review Mabthera Safety Reports submitted to FDA

Total Mabthera reports: 542.
Mabthera FDA safety alerts: No.
Reported deaths: 135    Reported hospitalizations: 273.
Take Mabthera Side Effects Survey, Discuss Mabthera with others
FDA Reported Mabthera Side Effects: neutropenia, pulmonary fibrosis, haemoglobin decreased, pyrexia, pulmonary embolism, respiratory failure, condition aggravated, febrile neutropenia, white blood cell count decreased, infusion related reaction, renal failure acute.
More About Mabthera.
If you have questions about Mabthera, you can ask a Health Expert or Ask Patient Community about Mabthera.

< Previous  Showing 201-300 of 542 Next >

Mabthera Side Effects Report #5337313-5
Physician from SWEDEN reported MABTHERA problem on May 21, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, liver abscess. MABTHERA dosage: 100 MG, UNK. During the same period patient was treated with METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5338528-2
MABTHERA problem was reported by a Health Professional from UNITED KINGDOM on May 18, 2007. Male patient, 62 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pneumonitis. MABTHERA dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient died on 01/01/2007.

Mabthera Side Effects Report #5340231-X
Physician from UNITED KINGDOM reported MABTHERA problem on May 21, 2007. Male patient, 56 years of age, weighting 143.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: muscle atrophy, neuralgia, paraesthesia, paresis. MABTHERA dosage: 700 MG, 2/MONTH. During the same period patient was treated with ONCOVIN, ENDOXAN, FARMORUBICIN, PREDNISONE, ZOFRAN, NAVOBAN. Patient recovered.

Mabthera Side Effects Report #5340487-3
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 23, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. MABTHERA dosage: 700 MG, UNK. During the same period patient was treated with FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5340517-9
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on May 22, 2007. Female patient was diagnosed with rheumatoid arthritis, pain, stomach discomfort and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder. MABTHERA dosage: 1000 MG, UNK. During the same period patient was treated with DICLOFENAC, PARACETAMOL, OMEPRAZOLE, DEXAMETHASONE, TAVEGIL. Patient recovered.

Mabthera Side Effects Report #5340877-9
MABTHERA problem was reported by a Consumer or non-health professional from EGYPT on May 20, 2007. Female patient, 36 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: peripheral ischaemia. MABTHERA dosage: 1000 MG, UNK. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5342371-8
Health Professional from FRANCE reported MABTHERA problem on May 25, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. MABTHERA dosage: 800 MG, UNK. During the same period patient was treated with ADRIAMYCIN PFS, ONCOVIN, OGAST, MOTILIUM, FORLAX, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5342432-3
MABTHERA problem was reported by a Physician from UNITED KINGDOM on May 21, 2007. Male patient, 50 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy, partial seizures, visual acuity reduced. MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.

Mabthera Side Effects Report #5343940-1
Health Professional from UNITED KINGDOM reported MABTHERA problem on May 25, 2007. Male patient, 62 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea, pneumonitis. MABTHERA dosage: 500 MG, 2/WEEK. During the same period patient was treated with METHOTREXATE, FOLIC ACID, CODEINE PHOSPHATE AND ACETAMINOPHEN. Patient died on 01/17/2007.

Mabthera Side Effects Report #5344361-8
MABTHERA problem was reported by a Physician from UNITED STATES on May 24, 2007. Female patient was diagnosed with vasculitis, pain and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, diplopia, disease progression, progressive multifocal leukoencephalopathy. MABTHERA dosage: 1000 MG, X2. During the same period patient was treated with OPIOID ANALGESICS NOS, PREDNISOLONE, AZATHIOPRINE, WARFARIN, HYDROCORTISONE. Patient was hospitalized. Patient died on 03/25/2007.

Mabthera Side Effects Report #5345798-3
Physician from AUSTRALIA reported MABTHERA problem on May 24, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hypertension, pulmonary oedema. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, ATENOLOL, ATORVASTATIN, ASPIRIN, RENITEC, ANTIHISTAMINE, BICARBONATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5345808-3
MABTHERA problem was reported by a Physician from UNITED KINGDOM on May 24, 2007. Female patient, 57 years of age, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin g decreased, herpes zoster, oesophageal candidiasis, pancytopenia. MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, AZATHIOPRINE. Patient recovered.

Mabthera Side Effects Report #5346297-5
Consumer or non-health professional from CHINA reported MABTHERA problem on May 30, 2007. Male patient, 71 years of age, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346524-4
MABTHERA problem was reported by a Physician from UNITED KINGDOM on May 31, 2007. Male patient, 49 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: leukocytosis, leukopenia, lymphocytosis, pyrexia. MABTHERA dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, METHOTREXATE. Patient recovered.

Mabthera Side Effects Report #5346536-0
Health Professional from FRANCE reported MABTHERA problem on May 30, 2007. Male patient, 57 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. MABTHERA dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, VINDESINE, ENDOXAN, BLEOMYCIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346609-2
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2007. Male patient, weighting 127.6 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346618-3
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on May 22, 2007. Female patient, weighting 123.5 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: facial palsy. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346630-4
MABTHERA problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on May 22, 2007. Female patient, weighting 141.1 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346645-6
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on May 22, 2007. Female patient, weighting 130.5 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5346656-0
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2007. Female patient, weighting 172.4 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MABTHERA dosage: 375 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5353094-3
Consumer or non-health professional from DENMARK reported MABTHERA problem on June 08, 2007. Male patient, 67 years of age, was diagnosed with skin disorder and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cardiac fibrillation. MABTHERA dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient recovered.

Mabthera Side Effects Report #5353102-X
MABTHERA problem was reported by a Physician from JORDAN on June 08, 2007. Male patient, weighting 176.4 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: encephalopathy. MABTHERA dosage: 500 MG, UNK. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5353112-2
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on June 08, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: mycosis fungoides, t-cell lymphoma. MABTHERA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5354570-X
MABTHERA problem was reported by a Physician from FRANCE on June 05, 2007. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. MABTHERA dosage: unknown. During the same period patient was treated with NIPENT, ZOFRAN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5357324-3
Physician from UNITED STATES reported MABTHERA problem on June 06, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: septic shock. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with ENZASTAURIN, GEMCITABINE, OXALIPLATIN, GRANOCYTE, LOVENOX, ACUPAN, LASIX. Patient died on 06/02/2007.

Mabthera Side Effects Report #5357687-9
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 08, 2007. Female patient, 62 years of age, was diagnosed with b-cell lymphoma, rheumatoid arthritis, hypertension, osteoporosis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: alveolitis, pulmonary fibrosis, respiratory failure. MABTHERA dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, PERINDOPRIL, CALCIUM CHLORIDE, ALPHA D. Patient recovered.

Mabthera Side Effects Report #5357888-X
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on June 05, 2007. Male patient, weighting 176.4 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: coma, respiratory failure. MABTHERA dosage: unknown. Patient died.

Mabthera Side Effects Report #5359463-X
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2007. Female patient, weighting 123.5 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: facial palsy. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5359544-0
Health Professional from UNITED KINGDOM reported MABTHERA problem on June 06, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: diarrhoea. MABTHERA dosage: 1000 MG, DAYS 1+15. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5361035-8
MABTHERA problem was reported by a Health Professional from UNITED KINGDOM on June 06, 2007. Male patient, 39 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pneumonitis, pulmonary fibrosis. MABTHERA dosage: 700 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, NEUPOGEN, PREDNISOLONE, RANITIDINE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5361073-5
Physician from FRANCE reported MABTHERA problem on June 06, 2007. Male patient, 75 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: coma. MABTHERA dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5361311-9
MABTHERA problem was reported by a Physician from FRANCE on June 02, 2006. Male patient, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: extremity necrosis, mouth ulceration, rash. MABTHERA dosage: 375 MG/M2, 1/MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #5362081-0
Physician from UNITED KINGDOM reported MABTHERA problem on June 11, 2007. Male patient, 63 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5364274-5
MABTHERA problem was reported by a Physician from SWEDEN on June 14, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: meningitis. MABTHERA dosage: 500 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5364290-3
Consumer or non-health professional from NETHERLANDS reported MABTHERA problem on June 12, 2007. Female patient, 49 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: transient ischaemic attack. MABTHERA dosage: 1000 MG, UNK. During the same period patient was treated with METHOTREXATE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #5365598-8
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 05, 2007. Male patient, weighting 176.4 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: coma, disease progression, respiratory failure. MABTHERA dosage: unknown. Patient died.

Mabthera Side Effects Report #5366984-2
Physician from UNITED KINGDOM reported MABTHERA problem on June 13, 2007. Male patient, 50 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: amnesia, leukoencephalopathy, partial seizures, visual acuity reduced. MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.

Mabthera Side Effects Report #5368040-6
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Female patient, 44 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome. MABTHERA dosage: unknown. During the same period patient was treated with OLANZAPINE, IMMUNE GLOBULIN INTRAVENOUS, ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5368099-6
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on June 15, 2007. Female patient, 62 years of age, was diagnosed with b-cell lymphoma, rheumatoid arthritis, hypertension, osteoporosis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: alveolitis, pulmonary fibrosis, respiratory failure. MABTHERA dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, PERINDOPRIL, CALCIUM CHLORIDE, ALPHA D. Patient recovered.

Mabthera Side Effects Report #5368519-7
MABTHERA problem was reported by a Physician from UNITED KINGDOM on June 15, 2007. Female patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: alveolitis, leukopenia, lymphocytosis, pyrexia. MABTHERA dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, METHOTREXATE, DECORTIN H. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5368638-5
Health Professional from UNITED KINGDOM reported MABTHERA problem on June 15, 2007. Male patient, 58 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant, prostatic specific antigen increased. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with DOXORUBICIN, PREDNISOLONE, ONCOVIN, ENDOXAN. Patient recovered.

Mabthera Side Effects Report #5369571-5
MABTHERA problem was reported by a Physician from SWEDEN on June 21, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: meningitis. MABTHERA dosage: 500 MG, UNK. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5370633-7
Physician from FRANCE reported MABTHERA problem on June 12, 2007. Female patient, 40 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: fibroma. MABTHERA dosage: unknown. During the same period patient was treated with ENBREL, HUMIRA, ARAVA, SALAZOPYRINE, METHOTREXATE, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5370892-0
MABTHERA problem was reported by a Pharmacist from UNITED KINGDOM on June 18, 2007. Female patient, weighting 125.7 lb, was diagnosed with neoplasm malignant and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: bulbar palsy. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5373477-5
Physician from UNITED KINGDOM reported MABTHERA problem on June 20, 2007. Male patient, 58 years of age, weighting 189.6 lb, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pruritus, rash vesicular, rhinitis, swelling face. MABTHERA dosage: 500 MG, UNK. During the same period patient was treated with METHOTREXATE. Patient recovered.

Mabthera Side Effects Report #5373829-3
MABTHERA problem was reported by a Consumer or non-health professional from FRANCE on June 20, 2007. Male patient, 17 years of age, was diagnosed with burkitt's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5374753-2
Physician from UNITED KINGDOM reported MABTHERA problem on June 20, 2007. Female patient, 60 years of age, was diagnosed with anaemia haemolytic autoimmune, thrombocytopenia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hepatitis viral. MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with LUMIGAN, ACTONEL, AZOPT, IMOVANE, DOLIPRANE, ENDOTELON, IDEOS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5375319-0
MABTHERA problem was reported by a Health Professional from NORWAY on June 21, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. MABTHERA dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5047231-8
Health Professional from AUSTRALIA reported MABTHERA problem on June 16, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, white blood cell count decreased. MABTHERA dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5047233-1
MABTHERA problem was reported by a Physician from AUSTRALIA on June 21, 2006. Female patient, 28 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. MABTHERA dosage: unknown. Patient died.

Mabthera Side Effects Report #5047234-3
Consumer or non-health professional from FRANCE reported MABTHERA problem on June 21, 2006. Female patient, 49 years of age, weighting 216.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: aphasia, bone marrow failure, brain compression, candida sepsis, cerebral haematoma, enterobacter sepsis, hemiparesis, hyperthermia, pancytopenia. MABTHERA dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, ETOPOPHOS, CYCLOPHOSPHAMIDE, CYTARABINE. Patient died on 05/16/2006.

Mabthera Side Effects Report #5048834-7
MABTHERA problem was reported by a Physician from UNITED KINGDOM on June 26, 2006. Female patient, 47 years of age, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, hypoxia, international normalised ratio increased, lung consolidation, pneumonia, white blood cell count decreased. MABTHERA dosage: unknown. During the same period patient was treated with FLUCONAZOLE, ACYCLOVIR, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 03/04/2005.

Mabthera Side Effects Report #5048838-4
Physician from SPAIN reported MABTHERA problem on June 26, 2006. Female patient, 66 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatitis acute, hepatitis cholestatic, hepatitis toxic, pneumonia, pseudomonal sepsis. MABTHERA dosage: 375 MG/M2, SINGLE, INTRAVENOUS. During the same period patient was treated with LORAZEPAM, CITALOPRAM HYDROBROMIDE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient died on 07/11/2002.

Mabthera Side Effects Report #5048839-6
MABTHERA problem was reported by a Physician from SOUTH AFRICA on June 20, 2006. Female patient, 61 years of age, weighting 198.4 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, coronary artery disease. MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ASPIRIN, PLAVIX, SIMVASTATIN. Patient recovered.

Mabthera Side Effects Report #5050818-X
Physician from SWEDEN reported MABTHERA problem on July 06, 2006. Male patient was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: optic nerve infarction, papilloedema. MABTHERA dosage: 700 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #5050819-1
MABTHERA problem was reported by a Physician from GERMANY on July 06, 2006. Female patient, 69 years of age, weighting 123.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: haematuria, haemolysis. MABTHERA dosage: 850 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, VORICONAZOLE, ALLOPURINOL, ESOMEPRAZOLE, INSULIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5050820-8
Physician from GERMANY reported MABTHERA problem on July 06, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 250 MG/M2, SINGLE, INTRAVENOUS. During the same period patient was treated with ZEVALIN. Patient recovered.

Mabthera Side Effects Report #5050822-1
MABTHERA problem was reported by a Physician from GERMANY on June 26, 2006. Male patient, 68 years of age, was diagnosed with mantle cell lymphoma and was treated with MABTHERA. MABTHERA dosage: unknown. Patient died on 05/11/2006.

Mabthera Side Effects Report #5050823-3
Physician from GERMANY reported MABTHERA problem on June 26, 2006. Male patient, 68 years of age, was diagnosed with mantle cell lymphoma and was treated with MABTHERA. MABTHERA dosage: unknown. Patient died on 05/11/2006.

Mabthera Side Effects Report #5052940-0
MABTHERA problem was reported by a Health Professional from SPAIN on June 29, 2006. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. MABTHERA dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5052945-X
Health Professional from SPAIN reported MABTHERA problem on June 29, 2006. Female patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: aspergillosis, bacteraemia, cytomegalovirus infection, dyspnoea, obliterative bronchiolitis, staphylococcal infection. MABTHERA dosage: 875 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, IDALPREM, VANOBID, CIPROFLOX, SEPTRINTE, ACYCLOVIR, VENTOLIN. Patient died on 08/21/2005.

Mabthera Side Effects Report #5053434-9
MABTHERA problem was reported by a Health Professional from SPAIN on June 29, 2006. Male patient, 56 years of age, weighting 187.4 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5053436-2
Physician from SWITZERLAND reported MABTHERA problem on July 03, 2006. Male patient, 31 years of age, was diagnosed with behcet's syndrome and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, neutropenia. MABTHERA dosage: 1000 MG, INTRAVENOUS. Patient recovered.

Mabthera Side Effects Report #5054075-X
MABTHERA problem was reported by a Health Professional from DENMARK on June 28, 2006. Male patient, 57 years of age, weighting 191.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatitis b, hepatotoxicity. MABTHERA dosage: 800 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, METFORMIN, SULFATRIM, ALMODAN, INSULIN, NEUPOGEN. Patient was hospitalized. Patient died on 04/25/2006.

Mabthera Side Effects Report #5054095-5
Physician from FRANCE reported MABTHERA problem on July 04, 2006. Female patient, child 12 years of age, was diagnosed with systemic lupus erythematosus and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: anuria, biopsy kidney abnormal, blood amylase increased, candidiasis, cellulitis, cerebral atrophy, colitis, convulsion, dialysis. MABTHERA dosage: 525 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CELLCEPT, THALIDOMIDE, NEORAL, COZAAR, PREDNISONE, COUMADIN, POLARAMINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5054490-4
MABTHERA problem was reported by a Physician from INDIA on July 10, 2006. Female patient, weighting 145.5 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 637.5 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient recovered.

Mabthera Side Effects Report #5055324-4
Health Professional from UNITED KINGDOM reported MABTHERA problem on July 03, 2006. Male patient, 52 years of age, weighting 198.4 lb, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. MABTHERA dosage: 10 MG, INTRAVENOUS. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, DIHYDROCODEINE, HYDROCORTISONE, OMEPRAZOLE, ACETAMINOPHEN, XENICAL. Patient recovered.

Mabthera Side Effects Report #5055325-6
MABTHERA problem was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, virus urine test positive, white blood cell count decreased. MABTHERA dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055326-8
Physician from KOREA, REPUBLIC OF reported MABTHERA problem on June 26, 2006. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: chest pain. MABTHERA dosage: 656 MG, INTRAVENOUS. During the same period patient was treated with CYTOXAN, VINCRISTINE. Patient died on 06/24/2006.

Mabthera Side Effects Report #5055465-1
MABTHERA problem was reported by a Health Professional from INDIA on July 10, 2006. Male patient, 57 years of age, weighting 127.9 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 615 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient recovered.

Mabthera Side Effects Report #5055917-4
Health Professional from AUSTRALIA reported MABTHERA problem on July 06, 2006. Male patient, 63 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. MABTHERA dosage: 800 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, VINCRISTINE, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055919-8
MABTHERA problem was reported by a Physician from SPAIN on July 06, 2006. Female patient, 52 years of age, weighting 167.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia. MABTHERA dosage: 670 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, QUINAPRIL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055926-5
Physician from UNITED STATES reported MABTHERA problem on July 03, 2006. Male patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: constipation. MABTHERA dosage: unknown. During the same period patient was treated with LAXATIVES. Patient recovered.

Mabthera Side Effects Report #5059940-5
MABTHERA problem was reported by a Health Professional from AUSTRALIA on July 06, 2006. Female patient, 80 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma. MABTHERA dosage: unknown. Patient died.

Mabthera Side Effects Report #5059941-7
Physician from FRANCE reported MABTHERA problem on July 06, 2006. Female patient, 19 years of age, weighting 121.3 lb, was diagnosed with autoimmune thrombocytopenia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. MABTHERA dosage: 375 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5059946-6
MABTHERA problem was reported by a Health Professional from AUSTRALIA on July 06, 2006. Female patient, 64 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma of skin. MABTHERA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5059949-1
Physician from AUSTRALIA reported MABTHERA problem on July 10, 2006. Male patient, 63 years of age, was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. MABTHERA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5059961-2
MABTHERA problem was reported by a Physician from SWITZERLAND on July 07, 2006. Female patient, 50 years of age, was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060178-6
Physician from SPAIN reported MABTHERA problem on July 06, 2006. Female patient, 63 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia. MABTHERA dosage: 637 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSHPAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, LEVOTHROID. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060247-0
MABTHERA problem was reported by a Health Professional from AUSTRALIA on July 06, 2006. Male patient, 56 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma of skin. MABTHERA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5060248-2
Physician from SWITZERLAND reported MABTHERA problem on July 03, 2006. Male patient, 31 years of age, was diagnosed with behcet's syndrome and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 1000 MG, INTRAVENOUS. Patient recovered.

Mabthera Side Effects Report #5060285-8
MABTHERA problem was reported by a Health Professional from BELGIUM on July 05, 2006. Male patient, 71 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: abscess, abscess bacterial, brain oedema, cerebral aspergillosis, cerebral toxoplasmosis, encephalitis herpes, haemoglobin decreased, immunodeficiency, nocardiosis. MABTHERA dosage: 500 MG/M2, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060286-X
Physician from FRANCE reported MABTHERA problem on July 11, 2006. Male patient, 78 years of age, weighting 165.3 lb, was diagnosed with mantle cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pulmonary hypertension. MABTHERA dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CALCIPARINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060295-0
MABTHERA problem was reported by a Physician from SPAIN on June 29, 2006. Male patient, 56 years of age, weighting 187.4 lb, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, nonspecific reaction. MABTHERA dosage: 500 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060296-2
Physician from SPAIN reported MABTHERA problem on July 12, 2006. Female patient, 66 years of age, weighting 153.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemoglobin decreased, staphylococcal infection. MABTHERA dosage: 375 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, SEPTRINTE, CITALOPRAM HYDROBROMIDE, ORPHOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060298-6
MABTHERA problem was reported by a Physician from FRANCE on July 10, 2006. Female patient, 76 years of age, weighting 134.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hydronephrosis. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5062754-3
Health Professional from SPAIN reported MABTHERA problem on July 12, 2006. Male patient, 73 years of age, weighting 170.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac arrest, chronic obstructive pulmonary disease, heart rate increased, hydropneumothorax, iatrogenic injury, obliterative bronchiolitis, viral upper respiratory tract infection. MABTHERA dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, NICOTINE, DIGOXIN, ATROVENT, GENTAMICIN, VENTOLIN. Patient died on 09/21/2005.

Mabthera Side Effects Report #5064905-3
MABTHERA problem was reported by a Physician from GERMANY on July 17, 2006. Female patient, 43 years of age, was diagnosed with dermatomyositis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, vasculitis. MABTHERA dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5064909-0
Physician from ARGENTINA reported MABTHERA problem on July 14, 2006. Female patient, 57 years of age, was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: cardiotoxicity, convulsion, dehydration, infusion related reaction, vomiting. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5064910-7
MABTHERA problem was reported by a Physician from NETHERLANDS on July 20, 2006. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, haemoglobin decreased. MABTHERA dosage: 375 MG/M2. Patient recovered.

Mabthera Side Effects Report #5066100-0
Physician from ARGENTINA reported MABTHERA problem on July 14, 2006. Female patient, 57 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5066858-0
MABTHERA problem was reported by a Physician from FRANCE on July 18, 2006. Male patient, 48 years of age, was diagnosed with leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. MABTHERA dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5066859-2
Health Professional from THAILAND reported MABTHERA problem on July 17, 2006. Female patient, 77 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dyspnoea, haemorrhage, hypokalaemia, hyponatraemia, hypotension, neutropenia, pharyngitis, pneumonia. MABTHERA dosage: 560 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISOLONE. Patient died on 07/08/2006.

Mabthera Side Effects Report #5067196-2
MABTHERA problem was reported by a Health Professional from AUSTRALIA on July 20, 2006. Male patient, 73 years of age, weighting 147.7 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: nephropathy toxic, pain in extremity. MABTHERA dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE, ALDACTONE, ALLOPURINOL, QUINAPRIL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5069558-6
Physician from SWITZERLAND reported MABTHERA problem on July 20, 2006. Male patient, 30 years of age, weighting 127.9 lb, was diagnosed with behcet's syndrome and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 1000 MG, INTRAVENOUS. Patient recovered.

Mabthera Side Effects Report #5099107-8
MABTHERA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2005. Female patient, 77 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: pneumonitis. MABTHERA dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with WARFARIN, IMMUNE GLOBULIN, PREDNISOLONE, DANAZOL. Patient recovered.

Mabthera Side Effects Report #5071716-1
Physician from FRANCE reported MABTHERA problem on July 21, 2006. Female patient, 68 years of age, weighting 158.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MABTHERA dosage: 820 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5071863-4
MABTHERA problem was reported by a Physician from FRANCE on July 20, 2006. Male patient, 75 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: neutropenia. MABTHERA dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ETOPOSIDE. Patient recovered.

Mabthera Side Effects Report #5071865-8
Physician from FRANCE reported MABTHERA problem on July 19, 2006. Male patient, 34 years of age, weighting 163.1 lb, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: respiratory disorder. MABTHERA dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, METHYLPREDNISOLONE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5072934-9
MABTHERA problem was reported by a Physician from AUSTRALIA on July 25, 2006. Female patient, 62 years of age, weighting 184.1 lb, was diagnosed with chronic lymphocytic leukaemia, pneumocystis jiroveci infection and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, cold sweat, lethargy, pain. MABTHERA dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with RESPRIMTE, CYCLOPHOSPHAMIDE, FLUDARABINE, LEVOTHYROXINE, PANCRELIPASE, ERGOCALCIFEROL, ESTRADIOL, NYSTATIN. Patient was hospitalized. Patient recovered.

< Previous  Showing 201-300 of 542 Next >

Ask Our Patient Community about Mabthera